Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-RLRPGGKKK^-OH
3D-Ansicht

Biosynth logo

H-RLRPGGKKK^-OH

Ref. 3D-PP41979

Unbestimmte GrößeNachfragen
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 2. Dezember 2024

Produktinformation

Name:
H-RLRPGGKKK^-OH
Beschreibung:

Peptide H-RLRPGGKKK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RLRPGGKKK^-OH include the following: Differential processing of influenza nucleoprotein in human and mouse cells VM Braud , AJ McMichael - European journal of , 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1521-4141(199802)28:02%3C625::AID-IMMU625%3E3.0.CO;2-I Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection TM Allen , M Altfeld, XG Yu , KM O'Sullivan - Journal of , 2004 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.78.13.7069-7078.2004 Transfer of Specificity for Human T Primary Human - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=b06f27fd2bdbff4563efae9aa367e1d757a03e4d Amplification of RNAi-targeting HLA mRNAs S Gonzalez, D Castanotto, H Li, S Olivares - Molecular Therapy, 2005 - cell.comhttps://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(05)00025-0 Spontaneous cytotoxic T-Cell reactivity against indoleamine 2, 3-dioxygenase-2 RB Sorensen, T Kollgaard, RS Andersen - Cancer research, 2011 - AACRhttps://aacrjournals.org/cancerres/article-abstract/71/6/2038/570998 Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with PJR Goulder , AK Sewell , DG Lalloo , DA Price - The Journal of , 1997 - rupress.orghttps://rupress.org/jem/article-abstract/185/8/1423/7136 SVMHC: a server for prediction of MHC-binding peptides P Dönnes , O Kohlbacher - Nucleic acids research, 2006 - academic.oup.comhttps://academic.oup.com/nar/article-abstract/34/suppl_2/W194/2505687 Putative Immunodominant Human Immunodeficiency Virus-Specific CD8+ T-Cell Responses Cannot Be Predicted by Major Histocompatibility Complex Class I MR Betts , JP Casazza, BA Patterson, S Waldrop - Journal of , 2000 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.74.19.9144-9151.2000 Vpr is preferentially targeted by CTL during HIV-1 infection M Altfeld, MM Addo , RL Eldridge, XG Yu - The Journal of , 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/5/2743/34449 Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes LJN Cooper, M Kalos, DA Lewinsohn - Journal of , 2000 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.74.17.8207-8212.2000 Immunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapy JP Casazza, MR Betts , BJ Hill, JM Brenchley - Journal of , 2005 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.79.6.3653-3663.2005 Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection H Horton, I Frank, R Baydo, E Jalbert - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/177/10/7406/74638 High Eomesodermin Expression among CD57+ CD8+ T Cells Identifies a CD8+ T Cell Subset Associated with Viral Control during Chronic Human F Simonetta , S Hua , C Lecuroux, S Gerard - Journal of , 2014 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02013-14 Newly exerted t cell pressures on mutated epitopes following transmission help maintain consensus HIV-1 sequences EM Eriksson, T Liegler, CE Keh, AC Karlsson - Plos one, 2015 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0120787 Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape E Lazaro, C Kadie , P Stamegna - The Journal of , 2011 - Am Soc Clin Investighttps://www.jci.org/articles/view/44932 TEpredict: software for T-cell epitope prediction DV Antonets, AZ Maksyutov - Molecular biology, 2010 - Springerhttps://link.springer.com/article/10.1134/S0026893310010152 HIV-1 Vpr does not inhibit CTL-mediated apoptosis of HIV-1 infected cells DA Lewinsohn, R Lines, DM Lewinsohn , SR Riddell - Virology, 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682201912942 Potentially exposed uninfected individuals make cytotoxic and polyfunctional HIV-1 specific CD8+ T cell responses, which can be defined to the epitope level AL Erickson, CB Willberg, V McMahan - Clinical and Vaccine , 2008 - researchgate.nethttps://www.researchgate.net/profile/Albert-Liu-3/publication/242281538_Potentially_exposed_uninfected_individuals_make_cytotoxic_and_polyfunctional_HIV1_specific_CD8_T_cell_responses_which_can_be_defined_to_the_epitope_level/links/00b4953a9f7df2bf82000000/Potentially-exposed-uninfected-individuals-make-cytotoxic-and-polyfunctional-HIV1-specific-CD8-T-cell-responses-which-can-be-defined-to-the-epitope-level.pdf

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP41979 H-RLRPGGKKK^-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.